Met Life Investment Management, LLC Aura Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,785 shares of AURA stock, worth $208,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,785
Previous 27,785
-0.0%
Holding current value
$208,387
Previous $247,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
39.9MCall Options Held
1.9KPut Options Held
31K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$51.9 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$36.6 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$30.6 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$22.8 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$22.5 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $220M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...